17&beta;-Hydroxysteroid dehydrogenases (17&beta;-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development.

Title:: 17β -Hydroxysteroid dehydrogenases (17β -HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development.
Author(s):: Marchais-Oberwinkler, S. ; Henn, C. ; Möller, G. ; Klein, T. ; Negri, M. ; Oster, A. ; Spadaro, A. ; Werth, R. ; Wetzel, M. ; Xu, K. ; Frotscher, M. ; Hartmann, R.W. ; Adamski, J.
Keywords:: Genetics and Epidemiology
Journal title:: J. Steroid Biochem. Mol. Biol.
Year:: 2011
Journal volume:: 125
Pages contribution:: 66-82
Fulltext / DOI:: doi:10.1016/j.jsbmb.2010.12.013
E-ISSN:: 0960-0760
Impact Factor:: 2,886
Notes:: Research Programmes: Genes and Environment in Common Diseases
TUM Institution:: Institute of Experimental Genetics (IEG)
BibTeX

Occurrences:

17&beta; -Hydroxysteroid dehydrogenases (17&beta; -HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development.